Nitroglycerin Administration Trim Project by Filomeno, Rosa
Baptist Health South Florida
Scholarly Commons @ Baptist Health South Florida
All Publications
6-17-2016
Nitroglycerin Administration Trim Project
Rosa Filomeno
Homestead Hospital, RosaFi@baptisthealth.net
Follow this and additional works at: https://scholarlycommons.baptisthealth.net/se-all-publications
This Conference Poster -- Open Access is brought to you for free and open access by Scholarly Commons @ Baptist Health South Florida. It has been
accepted for inclusion in All Publications by an authorized administrator of Scholarly Commons @ Baptist Health South Florida. For more
information, please contact Carrief@baptisthealth.net.
Citation
Filomeno, Rosa, "Nitroglycerin Administration Trim Project" (2016). All Publications. 2698.
https://scholarlycommons.baptisthealth.net/se-all-publications/2698
Sublingual nitroglycerin (SLNTG) is the first line drug 
of choice most commonly prescribed for chest pain 
and or in combination with morphine and oxygen 
(Gallagher, 2010).  Early recognition and management 
is essential to reduce patient’s mortality and improve 
patient’s outcome. 
In 2014, the staff of MS5 (Medical Surgical 5) 
identified SLNTG was not available in the Pyxis  63% 
of the time during some of the chest pain rapid 
response. This lead to delays in patient receiving 
much needed treatment and also cost the unit over 
$253.88 over a 3 month period due to lost SLNTG .
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Belkys Borgen, CPHT – HH Pharmacy System Specialist  
Winifred Pardo, PharmD, BCPS – HH Pharmacist
PTT-INR “The Project Think Tank for Innovation  in Nursing Research”-Consultation
• Developed an interdisciplinary team to brainstorm 
ideas on how to improve the process of SLNTG 
administration.
• To increase the availability of Nitroglycerin
• To reduce delays in administration of SLNTG        
during codes and or events  
• To reduce the waste of nitroglycerin
A T.R.I.M. (lean methodology) project was designed in 
collaboration with Pharmacy and Performance 
Improvement departments. 
By identifying barriers, streamlining dispensing 
process and bar-coding technology, SLNTG was 
dispensed only 3 pills at a time rather than a bottle. 
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As a result of MS5’s success, this innovative process 
was implemented hospital wide, on May 24, 2016, 
featured as a HH Magnet Designation story and 
presented at the Patient  Safety Symposium in 2016.
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Time: From Chest Pain to Administration of SLNTG
Once the project was implemented, data was collected 
to evaluate the target state.  
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Percentage 37% 100%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Pe
rc
en
t
Availability of SLNTG in Pyxis
SLNTG was available in 
the Pyxis 100% of the time 
during chest pain rapid 
response.
Reduced time of obtaining 
and administering SLNTG 
by 4 minutes.
Cost of administration went from $253.88 to $0.00 
dollars lost.
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